Drug Patent Expirations in April 2013

Drug Patent Expirations for April 2013

Tradename Applicant Generic Name Patent Number Patent Expiration
BROVANA Sunovion arformoterol tartrate 6,589,508 Apr 3, 2013
RAPLON Organon Usa Inc rapacuronium bromide 5,418,226 Apr 14, 2013
ACUTECT Cis Bio Intl Sa technetium tc-99m apcitide 5,508,020 Apr 16, 2013
NICODERM CQ Sanofi Aventis Us nicotine 5,508,038 Apr 16, 2013
GENOTROPIN PRESERVATIVE FREE Pharmacia And Upjohn somatropin recombinant 5,501,673 Apr 16, 2013
OXYCONTIN Purdue Pharma Lp oxycodone hydrochloride 5,508,042 Apr 16, 2013
CAVERJECT IMPULSE Pharmacia And Upjohn alprostadil 5,501,673 Apr 16, 2013
GENOTROPIN PRESERVATIVE FREE Pharmacia And Upjohn somatropin recombinant 5,435,076 Apr 16, 2013
AZOPT Alcon Pharms Ltd brinzolamide 5,461,081*PED Apr 24, 2013
ZELNORM Novartis tegaserod maleate 5,510,353 Apr 26, 2013
HYTRIN Abbott terazosin hydrochloride 5,412,095 Apr 29, 2013
HYTRIN Abbott terazosin hydrochloride 5,294,615 Apr 29, 2013
ALVESCO Takeda Gmbh ciclesonide 6,036,942 Apr 30, 2013
CEDAX Pernix Therap ceftibuten dihydrate 5,599,557 Apr 30, 2013
ZETONNA Takeda Gmbh ciclesonide 6,036,942 Apr 30, 2013
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.

Comments are closed.